受美国总统特朗普上周末威胁对丹麦、挪威、瑞典、法国、德国、荷兰、芬兰和英国八个欧洲盟国加征 关税影响，全球市场本周首个交易日迎来巨震。欧洲股市全线下挫，因假日休市，美股期指盘前跌逾 1%。 在地缘政治与经济前景动荡的背景下，投资者纷纷涌入避险资产，推动黄金与白银价格在时隔数日后再 度飙升至新高点。 关税威胁又来了 围绕格陵兰岛的争端，只是当前众多地缘政治热点之一。特朗普还在考虑介入伊朗国内动荡局势；与此 同时，美国政府威胁起诉美联储主席鲍威尔，这一消息再次引发外界对美联储独立性的担忧。近期华尔 街频繁上调黄金目标价，其中美银和摩根大通认为金价有望最终触及6000美元。 荷兰国际集团ING在发给第一财经记者的报告中写道，"特朗普此次的关税声明，将贸易紧张局势推向 了全新高度 ——此举的背后，经济逻辑的驱动成分减弱，政治动机的主导意味越发明显。这也将长期 以来的跨大西洋关系推入严重危机，局势存在明显的进一步升级风险，还会给欧美双方的经济带来无端 的负面后果。" 世界经济论坛年会本周即将在达沃斯召开，特朗普将出席此次会议。值得一提的是，论坛会前发布的年 度风险认知调查报告显示，国家间的经济对抗已取代武装冲突，成为全 ...

去年4月一幕是否会重演？ 受美国总统特朗普上周末威胁对丹麦、挪威、瑞典、法国、德国、荷兰、芬兰和英国八个欧洲盟国加征 关税影响，全球市场本周首个交易日迎来巨震。欧洲股市全线下挫，因假日休市，美股期指盘前跌逾 1%。 在地缘政治与经济前景动荡的背景下，投资者纷纷涌入避险资产，推动黄金与白银价格在时隔数日后再 度飙升至新高点。 关税威胁又来了 特朗普在社交媒体明确表示，若未能就全面收购格陵兰岛达成协议，自6月1日起，对上述所有国家的关 税税率将提升至25%。这些国家均为北约成员国，且在丹麦拒绝出售格陵兰岛一事上，一致选择支持丹 麦的立场。 预测市场正将格陵兰岛相关风险纳入定价模型。在Polymarket预测市场上，交易员目前认为，与格陵兰 岛相关的部分关税在2月1日前生效的概率为39%；分国家来看，丹麦和挪威面临关税的概率分别为36% 和35%，德国则为25%。长期预测显示，美国在2026年取得格陵兰岛部分地区控制权的概率为25%，而 美国对格陵兰岛发动军事入侵的概率相对较低，仅为11%。 受马丁路德金纪念日影响，美国股市与债市周一休市，因此此次关税威胁的首轮市场影响率先在欧洲本 土显现。泛欧斯托克600指数收跌 ...

（文章来源：证券日报） 证券日报网讯 1月19日，新里程在互动平台回答投资者提问时表示，截至2026年1月10日收盘，公司股 东人数为70366户。 ...

Core Viewpoint - The medical services sector experienced a decline of 1.45% on January 19, with Chengdu Xian Dao leading the drop. The Shanghai Composite Index rose by 0.29%, while the Shenzhen Component Index increased by 0.09% [1]. Group 1: Market Performance - The medical services sector saw a significant outflow of 1.45%, with Chengdu Xian Dao's stock price falling by 6.82% to 32.80 [2]. - Major stocks in the medical services sector included New Mileage, which rose by 9.83% to 2.57, and ST Biological, which increased by 5.06% to 8.93 [1][2]. - The total net outflow of main funds in the medical services sector was 1.983 billion, while retail investors saw a net inflow of 1.942 billion [2][3]. Group 2: Individual Stock Performance - New Mileage had a closing price of 2.57 with a trading volume of 3.1192 million shares, resulting in a transaction amount of 778 million [1]. - Chengdu Xian Dao, despite leading the decline, had a trading volume of 292,200 shares and a transaction amount of 976 million [2]. - The stock performance varied significantly, with some stocks like ST Biological and Huazhong Medical showing positive movements, while others like Chengdu Xian Dao and Meinian Health faced notable declines [2][3].

Market Overview - The Shanghai Composite Index closed at 4114.00 points, above the annual line, with a change of 0.29% [1] - The total trading volume of A-shares reached 27,322.16 million yuan [1] Stocks Breaking Annual Line - A total of 129 A-shares have surpassed the annual line today [1] - Notable stocks with significant deviation rates include: - Xinlicheng (8.92%) - Junzheng Group (8.59%) - Tiandi Online (7.60%) [1] Stock Performance Details - The following stocks showed notable performance: - Xinlicheng: Today's change of 9.83%, turnover rate of 9.53%, latest price at 2.57 yuan [1] - Junzheng Group: Today's change of 8.68%, turnover rate of 5.01%, latest price at 5.76 yuan [1] - Tiandi Online: Today's change of 9.99%, turnover rate of 7.71%, latest price at 20.26 yuan [1] - Other stocks with smaller deviation rates include: - Hemai Co., Ltd. - Wukuang Capital - Huadian Liaoning Energy [1]

Group 1 - The stock of Xinli Cheng has experienced a significant increase, with three limit-up days within five trading days, resulting in a cumulative increase of 13.22% and a turnover rate of 49.84% [2] - As of 10:09, the stock's trading volume reached 270 million shares, with a transaction amount of 669 million yuan, and a turnover rate of 8.24% [2] - The total market capitalization of A-shares is currently 8.706 billion yuan, with a circulating market value of 8.409 billion yuan [2] Group 2 - The latest margin trading balance for the stock is 357 million yuan, with a financing balance of 355 million yuan, which decreased by 60.94 million yuan compared to the previous trading day, reflecting a 14.64% decline [2] - Over the past five days, the margin trading balance has increased by 3.09 million yuan, showing a growth of 0.88% [2] - The stock has appeared on the Dragon and Tiger list twice due to a cumulative deviation in price of 20% over three consecutive trading days and a daily volatility of 15% [2] Group 3 - The net selling by the Shenzhen Stock Connect totaled 15.861 million yuan, while the total net selling by brokerage seats reached 59.4185 million yuan [2] - Recent trading performance shows fluctuations, with notable declines on January 15 and January 16, where the stock dropped by 5.45% and 10.00% respectively [2] - The main capital inflow and outflow data indicate significant negative net inflows on January 15 and January 16, with net outflows of 44.120 million yuan and 106.2079 million yuan respectively [2]

Market Overview - As of January 15, the Shanghai Composite Index closed at 4112.60 points, with a decline of 0.33%. The Shenzhen Component Index closed at 14306.73 points, increasing by 0.41%. The ChiNext Index closed at 3367.92 points, rising by 0.56% [1] Trading Volume Analysis - A total of 1255 stocks saw an increase in average transaction volume, with 15 stocks experiencing a growth of over 50%. Conversely, 3315 stocks reported a decrease in transaction volume. Notable stocks with significant increases include Wenke Co., Ltd., Shanhe Pharmaceutical, and Sanjia Technology [1] Active Stocks by Transaction Volume - The stocks with the highest increase in average transaction volume include: - Wenke Co., Ltd. (10.09% increase, 3841 shares, 241.99% increase) - Shanhe Pharmaceutical (20.01% increase, 1613 shares, 125.77% increase) - Sanjia Technology (9.99% increase, 983 shares, 112.27% increase) [2] Active Stocks by Transaction Count - The stocks with the highest increase in transaction count include: - Sanwei Communication (481,875 transactions, 10799.68% increase) - ST Keli Da (3,235 transactions, 3797.59% increase) - Sanjiang Shopping (128,956 transactions, 3237.37% increase) [3] Stocks with Significant Increases in Both Volume and Count - Shanhe Pharmaceutical stands out with a 20.01% increase in price, an average transaction volume of 1613 shares (125.77% increase), and a transaction count of 25,673 (98.97% increase) [4] - Other notable stocks include: - Jiangshan Co., Ltd. (9.99% increase, 795 shares, 97.34% increase, 38,300 transactions, 61.17% increase) - Dibei Electric (10.01% increase, 921 shares, 61.43% increase, 18,200 transactions, 244.11% increase) [5]

Core Viewpoint - The stock price of Xinlicheng has experienced an abnormal fluctuation, with a cumulative increase of over 20% in the closing price over two consecutive trading days, prompting a self-examination by the company which found no violations of information disclosure regulations [1] Company Summary - Xinlicheng is primarily engaged in the production and sales of pharmaceuticals and hospital management [1] - For the period from January to September 2025, Xinlicheng reported a revenue of 2.256 billion yuan, representing a year-on-year decline of 23.40% (adjusted) [1] - The company incurred a net loss of 38 million yuan, with the loss expanding by 167.83% year-on-year (adjusted) [1] Industry Summary - On January 13, the Ministry of Civil Affairs and seven other departments issued measures to cultivate the operating entities in the elderly care service sector and promote the development of the silver economy, proposing 14 specific measures across five areas [1]

（文章来源：证券时报网） 数据宝统计，截至09:40，新里程成交额10.41亿元，创2024年12月27日以来新高。最新股价上涨 2.91%，换手率10.99%。上一交易日该股全天成交额为2.01亿元。（数据宝） ...

Core Viewpoint - The company, Xinliming, announced that its stock price experienced an abnormal fluctuation, with a cumulative closing price increase of over 20% over two consecutive trading days (January 13 and January 14, 2026) [1] Group 1 - The company confirmed that there are no corrections or supplements needed for previously disclosed information [1] - No significant undisclosed major information has been reported in public media that could have impacted the company's stock price [1] - The company's operational activities are normal, and there have been no significant changes in its disclosed business conditions or external operating environment [1]